Updated: May 10, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
A Küllmer1, G Herrmann, B Riecken
1Klinik für Innere Medizin, Gastroenterologie, Hämato-Onkologie, Infektiologie und Diabetologie, Ludwigsburg. armin.kuellmer@kliniken-lb.de
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
A patient with Richter's syndrome developed progressive multifocal leukoencephalopathy (PML) during rituximab and bendamustine treatment. Neurological symptoms during rituximab therapy warrant investigation for PML.
Area of Science:
Background:
Observation:
Findings:
Implications: